BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 12000200)

  • 1. Does depression hurt?
    Stahl SM
    J Clin Psychiatry; 2002 Apr; 63(4):273-4. PubMed ID: 12000200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression.
    Fava M
    J Clin Psychiatry; 2003; 64 Suppl 13():26-9. PubMed ID: 14552653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common pathways of depression and pain.
    Delgado PL
    J Clin Psychiatry; 2004; 65 Suppl 12():16-9. PubMed ID: 15315473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine dysfunction and the pathophysiology and treatment of depression.
    Charney DS
    J Clin Psychiatry; 1998; 59 Suppl 14():11-4. PubMed ID: 9818625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norepinephrine involvement in antidepressant action.
    Frazer A
    J Clin Psychiatry; 2000; 61 Suppl 10():25-30. PubMed ID: 10910014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical symptoms comorbid with depression and the new antidepressant duloxetine.
    Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2003 Dec; 41(12):13-8. PubMed ID: 14682027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of antidepressants: selectivity or multiplicity?
    Westenberg HG
    J Clin Psychiatry; 1999; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In the treatment of depression, does selectivity of action matter?
    J Clin Psychiatry; 2004; 65 Suppl 4():60-2. PubMed ID: 15046543
    [No Abstract]   [Full Text] [Related]  

  • 9. Serotonergic mechanisms and the new antidepressants.
    Stahl SM
    Psychol Med; 1993 May; 23(2):281-5. PubMed ID: 8332642
    [No Abstract]   [Full Text] [Related]  

  • 10. New developments in the neurobiological basis of anxiety disorders.
    Gorman JM; Hirschfeld RM; Ninan PT
    Psychopharmacol Bull; 2002; 36 Suppl 2():49-67. PubMed ID: 12490823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of duloxetine on painful physical symptoms associated with depression.
    Goldstein DJ; Lu Y; Detke MJ; Hudson J; Iyengar S; Demitrack MA
    Psychosomatics; 2004; 45(1):17-28. PubMed ID: 14709757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The psychopharmacology of painful physical symptoms in depression.
    Stahl SM
    J Clin Psychiatry; 2002 May; 63(5):382-3. PubMed ID: 12019660
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence-based treatment paradigms for depressed patients with pain and physical symptoms.
    Fishbain DA
    J Clin Psychiatry; 2009 Jul; 70(7):e22. PubMed ID: 19653968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of norepinephrine in depression.
    Delgado PL; Moreno FA
    J Clin Psychiatry; 2000; 61 Suppl 1():5-12. PubMed ID: 10703757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dual-action hypothesis: does pharmacology matter?
    Shelton RC
    J Clin Psychiatry; 2004; 65 Suppl 17():5-10. PubMed ID: 15600376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of painful physical symptoms in the treatment of Japanese patients with melancholic major depressive disorder: A prospective cohort study.
    Sekine A; Hozumi S; Shimizu T
    Psychiatry Res; 2016 Aug; 242():240-244. PubMed ID: 27294798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of norepinephrine in the treatment of depression.
    J Clin Psychiatry; 1999 Sep; 60(9):623-31. PubMed ID: 10520985
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.
    Miller HL; Delgado PL; Salomon RM; Berman R; Krystal JH; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1996 Feb; 53(2):117-28. PubMed ID: 8629887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
    Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
    Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.